Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.835
+0.145 (5.39%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Cellectis Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 63.82 | 79.59 | 49.22 | 9.19 | 25.72 | 38.6 |
Revenue Growth | 0.61% | 61.72% | 435.38% | -64.26% | -33.35% | -35.20% |
Gross Profit Gross Profit Growth | 63.82 | 79.59 | 49.22 | 8.46 | 23.95 | 36.75 |
Operating Income Operating Income Growth | -58 | -33.08 | -59.55 | -97.3 | -89.67 | -103.48 |
Net Income Net Income Growth | -65.31 | -67.59 | -36.76 | -101.06 | -121.49 | -114.2 |
Earnings Per Share EPS Growth | -0.65 | -0.67 | -0.41 | -1.77 | -2.33 | -2.55 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
France France Growth | 56.58 | 72.95 | 41.51 | 0.76 | 19.17 | 30.35 |
Unallocated Unallocated Growth | 7.25 | 6.64 | 7.71 | 8.44 | 6.55 | 8.25 |
Total Total Growth | 63.82 | 79.59 | 49.22 | 9.19 | 25.72 | 38.6 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 166.85 | 208.66 | 260.31 | 203.82 | 97.7 | 186.14 |
Total Debt Total Debt Growth | 104.28 | 119.9 | 109.65 | 105.86 | 82.85 | 102.24 |
Net Cash (Debt) Net Cash Growth | 62.57 | 88.76 | 150.66 | 97.95 | 14.85 | 83.9 |
Net Cash Growth | -25.80% | -41.08% | 53.81% | 559.74% | -82.30% | -46.54% |
Net Cash Per Share Net Cash Per Share Growth | 0.62 | 0.89 | 1.66 | 1.72 | 0.33 | 1.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -41.63 | -39.4 | 22.99 | -24.75 | -87.44 | -104.56 |
Capital Expenditures CapEx Growth | -2.18 | -2.36 | -2.58 | -1.07 | -2.43 | -18.54 |
Free Cash Flow Free Cash Flow Growth | -43.8 | -41.76 | 20.41 | -25.82 | -89.88 | -123.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 100.00% | 100.00% | 100.00% | 91.98% | 93.11% | 95.22% |
Operating Margin | -90.87% | -41.56% | -121.00% | -1058.44% | -348.57% | -268.11% |
Pretax Margin | -102.88% | -85.45% | -74.69% | -1266.89% | -383.30% | -250.66% |
Profit Margin | -102.34% | -84.92% | -74.69% | -1179.63% | -443.30% | -324.14% |
FCF Margin | -68.63% | -52.47% | 41.46% | -280.85% | -349.38% | -318.95% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | 2.47 | - | - | - |
PS Ratio | 3.17 | 6.10 | 1.02 | 24.04 | 3.73 | 9.57 |